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A new route for the synthesis of 2-benzoxepin-3(1H)-ones derivatives has been devised starting 
from Heck reaction, subsequent reduction followed by base mediated cyclization. The initial 
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Facile synthesis of 2-benzoxepin-3(1H)-ones 
 
 
1.1 INTRODUCTION:   
      
Natural products have been used to be a rich source of lead molecules in drug discovery. Natural 
products have played a major role in the invention of numerous medicines. The combination of 
synthetic organic chemistry and combinatorial chemistry strategies such as diversity-oriented 
synthesis (DOS) have enabled the synthesis and improved the desired of biological properties of 




Compounds having α,β-unsaturated lactones display a wide variety of biological activities. Many 
research groups have tested both natural and unnatural α,β-unsaturated lactones for as-yet 
undiscovered biological properties (Figure 1).
[2] 
 
   
 
   
Figure 1. Various lactones reported in literature.  
 
Among them, 7-membered ring lactones are ubiquitous framework of many natural products of 
interest but they are difficult to prepare by conventional methods.
[3]  
Particularly, compounds 
with a benzoxepine moiety includes anti-inflammatory, analgesic, and various other types of 
biological activities.
[4] 
This arises great interest towards the functionalization of benzoxepin 
skeleton. 
 
1.2 Isolation from natural source: 
 
Endophytes are rich sources of new secondary metabolite which are having astonishing chemical 
diversity.
[5] 
The fermentation broth of cultured Pestalotiopsis virgatula isolated TC-320 from 
Terminalia chebula Retz. (Combretaceae) disclosed the presence of a simple but unprecedented 
low-molecular-weight metabolite, 9-hydroxybenzo[c]oxepin-3[1H]-one.
[5] 
Also a new 
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benzoxepin derivative had been isolated from Phomopsis strain, KS-37-2, which was isolated 




1.3 Biological Activity:   
The 2-benzoxepin-3(1H)-ones are not only present as basic core structure in antibiotics xylarinol 
(A) and xylarinol (B)
[7]
 but also forms the part structure of new tyrosinekinase (p56lck) inhibitor 
ulocladol
[8]
 and cytotoxic alterlactone.
[9]
 Analogues of 2-benzoxepin-3(1H)-ones have also been 
reported to exhibit analgesic activities (Figure 2).  
 
 
Figure 2. Representative examples of naturally occurring benzoxepin-3(1H)-one. 
 
1.4 Background study: 
A number of methods have been reported in literature for the synthesis of various derivatives of 
7-membered lactenones. Among them, few are discussed as:  
Cheng designed a highly regio, stereo selective and novel method for the synthesis of 7-
membered lactones. This method is bimetallic cyclization of 2-iodobenzyl alcohols with alkyl 








Scheme 1. Cheng approach for the Synthesis of Seven-membered Lactones 
 
In 2008, Kirillov developed a new method for the synthesis of 7-membered α,β-unsaturated 
lactones, where alkyl-1,3-dihydro-3-oxobenzo[c]oxepine-4-carboxylates were obtained by 
bromination of dialkyl-2-(2-methylbenzylidene) malonates with N-bromosuccinimide (NBS) 
followed by the cyclization of dialkyl-2-(2-bromomethylbenzylidene) malonates by heating 
compound for 1 h at 190 °C led the liberation of bromomethane, and a cyclization occurred 
providing methyl 1,3-dihydro-3-oxobenzo-[c]oxepine-4-carboxylate.
[11]
   
 
 
Scheme 2. Kirillov’s method for the synthesis of 7-membered lactones  
 
 In continuation of our ongoing research interest on transition-metal catalysis and 
domino/sequential one-pot processes, we have recently reported a sequential one-pot 
intermolecular oxy-Michael addition, subsequent intermolecular Heck coupling with the Michael 




Scheme 3. Sequential one-pot process for the synthesis of benzoxepines.  
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With this background, we have outlined another synthetic strategic route for the synthesis of 
benzoxepin-3(1H)-ones. The ultimate aim of this strategy is to use the carbonyl ester for the 
synthesis of benzoxepines. Next step is the selective reduction of carbonyl group with mild 
reducing agent such as NaBH4 followed by base mediated cyclization.  
 
1.5 Result and Discussion:   
The general strategy for the synthesis of 2-benzoxepin-3(1H)-ones is as shown in the 
retrosynthetic analysis (Scheme 4). Our approach involves the key intramolecular [Pd]-catalyzed 
C-O bond formation. The required procedure involves Pd-catalyzed Heck reaction on ortho-
bromo benzaldehyde to obtain corresponding ester, subsequent reduction with NaBH4 followed 
by base mediated intramolecular condensation to obtain cyclized product.   
 
 
Scheme 4. Retrosynthetic Analysis of 2-Benzoxepin-3(1H)-ones. 
 
In this strategy, step-1 follows the synthesis of carbonyl ester through Pd-catalyzed Heck 
reaction
[13]
 on ortho-bromobenzaldehydes with ethyl acrylate. ortho-Bromobenzaldehydes are 
obtained through bromination
[14]
 of commercially available aromatic aldehydes. Various 
attempts had been carried out using different solvents and bases using Pd(OAc)2 (5 mol%) as 
catalyst and PPh3 (10 mol%) as ligand. Interestingly, it was found that combination of strong 
base (such as Cs2CO3) and CH3CN as solvent had given Aldol condensation product (Table 1, 
entry 1). While switching to milder conditions, such as using NEt3 as base and CH3CN as 
solvent, furnished desired product 10a but with moderate yields (Table 1, entry 2). Various 
feasibilities were carried out and found that NEt3 and toluene is the best condition for obtaining 
aldehyde esters with excellent yields (Table 1, entry 3). After the attainment of 10a, to check the 
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extent and limitations of the present method, these optimized conditions were applied to the 
other systems of bromoaldehydes 9a-9h. The structures of aldehyde ester products (10a-10h) 
were further confirmed by NMR data analysis. Presence of the molecular ion peak at m/z 
317.1000 (C15H18NaO6)
+
 in the mass spectrum and from the 
1
H NMR spectrum (Figure 3a), 
presence of one singlet at  10.13 (CH=O) and two doublets at 8.04 (ArCH=CHCOOEt) and 
6.21 (ArCH=CHCOOEt), established the structure of 10h. The appearance of the one doublet 
at 189.9 (CH=O) and one singlet at COEt in the 13C NMR (Figure 3b), spectrum 
established the structure of 10h. 
 


































80 19 - - 36 




Et3N (1.0) CH3CN 
(2) 
80 22 58 - - 




Et3N (3) toluene (2) 110 24 90 - - 




Et3N (3) toluene (2) 110 24 - 33 - 




Et3N (3) DMF (2) 150 24 - 60 - 








110 24 - 84 - 
 [a] 
Isolated yields of the pure products. 
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Figure 3a. 1H NMR (400 MHz) spectrum of 10h in CDCl3   














































































Figure 3b. 13C NMR (100 MHz) spectrum of 10h in CDCl3   
 
Further to obtain various analogues, methyl-Grignard reaction was carried out on ortho-
bromoaldehydes which yielded secondary alcohols. The oxidation of these secondary alcohols 
15 
 






















 [a]  Isolated yields of the pure products. 
 
To this ortho-bromoketones Pd catalysed Heck reaction was carried out to obtain various 
acetophenone-esters. Similar conditions (i.e. NEt3 as base and toluene as solvent) were applied 
on ortho-bromoacetophenones but we obtain desired product with low yield (Table 1, entry 4). 
Another attempt was carried out using DMF instead of toluene as solvent. We were successful in 
our desired target but with moderate yield (Table 2, entry 5). In order to explore different 
conditions we tried with Hunig’s base and toluene, which results in corresponding acetophenone 
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esters in very good yields (Table 1, entry 6). Notably, it was found that NEt3 is not a suitable 
base for bromo-acetophenones. The structures of acetophenone ester products (14a-14h) were 
further confirmed by NMR data analysis. Presence of the molecular ion peak at m/z 331.1151 
(C16H20NaO6)
+
 in the mass spectrum and from the 
1
H NMR spectrum (Figure 4a), absence of 
singlet for CH=O and presence of two doublets at 7.78 (ArCH=CHCOOEt) and 6.29 
(ArCH=CHCOOEt), established the structure of (14h). The appearance of the two singlets at 
202.3 (C=O) and COEt in the 13C NMR (Figure 4b), spectrum established the 
structure of 14h. 
 


























































































 Figure 4a. 1H NMR (400 MHz) spectrum of 14h in CDCl3     













































































 Figure 4b.13C NMR (100 MHz) spectrum of 14h in CDCl3  
 
Selective reduction had been carried out at carbonyl centre with mild reducing agent. As known 
from literature,
[15]
 NaBH4 has been used for selective reduction at carbonyl centre in presence of 
ester group. So, reduction was carried out with NaBH4 in MeOH. Interestingly, it was observed 
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that not only carbonyl group but also double bond had also been reduced. It also results in trans-
esterification products. Initially reduction was carried out with NaBH4 in MeOH at -20 C. We 
obtained mixture of products 15a (6%) and 16 (30%) (Table 5, entry 1). We achieved our target 
product but with very low yield. Further studies had been carried out with decreasing the 
temperature to -40 C. Here, also results are same but the yield of our desired product had 
increased to 24% (Table 5, entry 2). To check the feasibility various reactions were carried out at 
different temperatures and found that at 0 C it results in trans-esterification product (Table 5, 
entry 3). In literature,
[16]
 the combination of NaBH4 and CeCl3.7H2O has been used for selective 
reduction at carbonyl centre in presence of various other reactive functional groups. So, we used 
CeCl3.7H2O along with NaBH4 in MeOH. We succeeded in our attempt but results in moderate 
yields (Table 5, entry 5). Once, we had used NaBH4 and CH3COOH as solvent instead of MeOH. 
Here, not only we achieved our desired product but also we were successful in obtaining 
excellent yields (Table 5, Entry 6). The structures of primary alcohol ester products (15a-15h) 
were further confirmed by NMR data analysis. Presence of the molecular ion peak at m/z 
319.1153 (C15H20NaO6)
+
 in the mass spectrum and from the 
1
H NMR spectrum (Figure 5a), 
presence of two doublets at 7.78 (ArCH=CHCOOEt) and 6.55 (ArCH=CHCOOEt) and one 
br. s, at (CH2OH) established the structure of 15h. The absence of signals for CH=O and 
appearance of the one singlet at COEt in the 13C NMR (Figure 5b), spectrum 
established the structure of 15h. 
 



























1 2.0 - 4.0 - - 1.5  20 6 30 - 
2 2.0 - 4.0 - - 2.0  40 24 12  
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3 2.0 - 4.0 - - 4.0 0 - - 40 
4 3.0 - 4.0 - - 24 rt - 83 - 
5 2.0 1.0 4.0 - - 6  20 to rt 68 - - 
6 4.0 - - 1.5 - 1.5 rt 89 - - 
7 3.0 - - - 3.0 24 rt - - - 
[a] 
Isolated yields of the pure products. 
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Figure 5a. 1H NMR (400 MHz) spectrum of 15h in CDCl3 
 












































































 Figure 5b. 13C NMR (100 MHz) spectrum of 15h in CDCl3 
For reduction of acetophenone ester, we first thought to apply the same strategy (i.e. NaBH4 in 
CH3COOH) as described in case of aldehyde ester. However, this method is not successful in 
case of secondary alcohols as we recovered starting material (Table 7, entry 1). So, we switched 
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to previous strategy of reduction i.e. combination of CeCl3.7H2O and NaBH4 in MeOH for 
selective reduction at carbonyl centre. The optimization of the reaction is given below (Table 7). 
Presence of the molecular ion peak at m/z 303.1201 (C15H20NaO5)
+
 in the mass spectrum and 
from the 
1
H NMR spectrum (Figure 6a), presence of two doublets at 7.93 (ArCH=CHCOOEt) 
and 6.21 (ArCH=CHCOOEt) and one br. s, at (CH2OH) established the structure of 18g. 
The absence of signals for C=O and appearance of the one singlet at COEt in the 
13
C NMR (Figure 6b) spectrum established the structure of 18g. 
 



















1 2.0 - - 1 2 rt - 
2 5.0 - - 3 2.0 100    - 
3 5.0 2.0 5.0 - 4.0 -20 to rt 37 
4 2.0 1.0 3.0 - 12 -20 to rt 78 
[a] 

















Isolated yields of the pure products. 
 
 
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm




































































H NMR (400 MHz) spectrum of 18g in CDCl3   
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C NMR (100 MHz) spectrum of 18g in CDCl3   
From our previous literature
 [12]
 we had found that intramolecular cyclization’s were carried 
using Cs2CO3 as base and DMF as solvent. Hence, the final step i.e. base promoted 
intramolecular cyclization reaction was carried out at similar conditions and we got succeeded in 
obtaining desired product with good yields.    






                           [a] 
Isolated yields of the pure products. 
 
Presence of the molecular ion peak at m/z 251.0913 (C13H15O5)
+
 in the mass spectrum and from 
the 
1
H NMR spectrum (Figure 7a), absence of quartet at  (OCH2CH3), triplet at 
CH2CH3 and one br. s, at (CH2OH) established the structure of 19h. The 
absence of signals at  OCH2CH3 and  OCH2CH3 in the 
13
C NMR (Figure 7b), 







































 Figure 7a. 1H NMR (400 MHz) spectrum of 19h in CDCl3.   
 



















































































 Isolated yields of the pure products. 
 
Presence of the molecular ion peak at m/z 287.0890 (C14H16NaO5)
+
 in the mass spectrum and 
from the 
1
H NMR spectrum (Figure 8a), absence of quartet at  (OCH2CH3), triplet at 
OCH2CH3 and one br. s, at (CH2OH) established the structure of 20h. The 
absence of signals at  OCH2CH3 and  OCH2CH3 in the 
13
C NMR (Figure 8b), 



























































 Figure 8a. 
1
H NMR (400 MHz) spectrum of 20h in CDCl3  
   













































































1.6 Conclusion:   
We have developed a short and efficient strategy for the synthesis of functionalized 2-
benzoxepin-3(1H)-ones using Pd-catalysed Heck coupling and reduction followed by 
intramolecular cyclization protocol. Significantly, these systems found in naturally occurring 
biologically active compounds. Initial step involves C-C bond formation whereas final 
cyclization step involves the formation of C-O bond through unprecedented condensation 
reaction path promoted by base.    
  
 














1.7 Experimental Section 
General: IR spectra were recorded on a Bruker Tensor 37 (FT-IR) spectrophotometer. 
1
H 
NMR spectra were recorded on BrukerAvance 400 (400 MHz) spectrometer at 295 K in CDCl3; 
chemical shifts (δ in ppm) and coupling constants (J in Hz) are reported in standard fashion with 
reference to either internal standard tetramethylsilane (TMS) (δH =0.00 ppm) or CHCl3 (δH = 
7.25 ppm). 
13
C NMR spectra were recorded on BrukerAvance 400 (100 MHz) spectrometer at 
RT in CDCl3; chemical shifts (δ in ppm) are reported relative to CHCl3 [δC = 77.00 ppm (central 
line of triplet)]. In the 
13
C NMR, the nature of carbons (C, CH, CH2 and CH3) was determined by 
recording the DEPT-135 spectra, and is given in parentheses and noted as s = singlet (for C), d = 
doublet (for CH), t = triplet (for CH2) and q = quartet (for CH3). In the 
1
H-NMR, the following 
abbreviations were used throughout: s = singlet, d = doublet, t = triplet, q = quartet, qui =quintet, 





C CPD and DEPT spectra. High-resolution mass spectra (HR-MS) were 
recorded on an Agilent 6538 UHD Q-TOF using multimode source. All small scale dry reactions 
were carried out using standard syringe-septum technique. Reactions were monitored by TLC on 
silica gel using a mixture of petroleum ether and ethyl acetate as eluents. Reactions were 
generally run under an argon or nitrogen atmosphere. All Solvents were distilled prior use; 
petroleum ether with a boiling range of 60 to 80 C, diethyl ether, dichloromethane (DCM), ethyl 
acetate, toluene, were used which are purchased from locally available commercial sources. All 
aromatic aldehydes, bromine, iodine, magnesium metal, methyliodide, 4 A Molecular sieves, 
sodium metal, silica gel (60–120 mesh), triethylamine (Et3N) were used which are purchased 
from locally available commercial sources. Palladium(II)acetate, PPh3 ethyl acrylate, 
diisopropylethylamine (DIPEA) were purchased from sigma-Aldrich which were used without 
further purification. Cs2CO3 dried at 150–170 

C over oil bath. DMF dried over CaH, diethyl 
ether and toluene were dried over benzophenone/sodium. Acme’s silica gel (60–120 mesh) was 
used for column chromatography (approximately 20 g per one gram of crude material). 
 
General Procedure-1 for Pd-mediated heck reaction on ortho-bromobenzaldehyde (9a-9h): 
To a stirred solution of an oven dried Schlenk tube under nitrogen atmosphere, were added 
ortho-bromobenzaldehyde 9a-9h (2.0 mmol), Pd(OAc)2 (5 mol%), PPh3 (10 mol%), Et3N (6.0 
mmol), dry toluene (5 mL) and followed by addition of ethyl acrylate (6.0 mmol). The resulted 
reaction mixture was stirred at 110 C for 24 h. The reaction mixture was quenched by addition 
of aqueous NH4Cl and the aqueous layer was extracted with ethyl acetate (3  20 mL). The 
combined organic layers were dried (Na2SO4) and concentrated in vacuo. The crude product 10a-







Ethyl (2E)-3-(2-formylphenyl)acrylate (10a): General procedure-1 was carried out with ortho-
bromobenzaldehyde 9a (370 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 mmol), PPh3 (52.4 mg, 
0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate (0.65 mL, 6.0 
mmol) at 110 C for 24 h [TLC control Rf(9a)=0.85, Rf(10a)=0.55 (petroleum ether/ethyl acetate 
90:10, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 
95:5 to 90:10) gave title compound 10a (367 mg, 90%), yellow viscous liquid. IR (MIR-ATR, 





H NMR (CDCl3, 400 MHz): δ=10.28 (s, 1H, CHO), 8.50 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 7.86 (dd, 1H, J=7.3 and 1.0 Hz, Ar-H), 7.65–7.50 (m, 3H, Ar-H), 6.36 (d, 
1H, J=16.1 Hz, ArCH=CHCOOEt), 4.27 (q, 2H, J=7.3 Hz, OCH2CH3), 1.33 (t, 3H, J=7.3 Hz, 
OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=191.7 (d, CH=O), 166.2 (s, O=COEt), 140.9 
(d, Ar-CH=CHCOOEt), 136.6 (d, Ar-CH), 133.9 (d, Ar-CH), 133.8 (s, Ar-C), 132.1 (d, Ar-CH), 
129.8 (d, Ar-CH), 127.9 (d, Ar-CH), 123.2 (d, Ar-CH=CHCOOEt), 60.7 (t, OCH2CH3), 14.2 (q, 








Ethyl (2E)-3-[4-(benzyloxy)-2-formylphenyl]acrylate (10b): General procedure-1 was carried 
out with ortho-bromobenzaldehyde 9b (452 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 mmol), 
PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate 
(0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9b)=0.80, Rf(10b)=0.60 (petroleum 
ether/ethyl acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 90:10 to 80:20) gave title compound 10b (465 mg, 75%), as yellow solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 84–86 C. IR (MIR-
ATR, 4000–600 cm-1): max=2922, 2852, 1705, 1599, 1495, 1455, 1291, 1258, 1179, 1159, 1097, 




H NMR (CDCl3, 400 MHz): δ=10.31 (s, 1H, CHO), 8.43 (d, 1H, 
J=15.6 Hz, ArCH=CHCOOEt), 7.59 (d, 1H, J=8.8 Hz, Ar-H), 7.55–7.30 (m, 6H, Ar-H), 7.19 
(dd, 1H, J=8.8 and 2.9 Hz, Ar-H), 6.31 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 5.13 (s, 2H, 
PhCH2O), 4.26 (q, 2H, J=7.3 Hz, OCH2CH3), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR 
(CDCl3, 100 MHz): δ=190.9 (d, CH=O), 166.4 (s, EtOC=O), 160.0 (s, Ar-C), 139.6 (d, Ar-
CH=CHCOOEt), 135.8 (s, Ar-C), 135.0 (s, Ar-C), 129.5 (s, Ar-C), 129.4 (d, Ar-CH), 128.7 (d, 
32 
 
2C, Ar-CH), 128.3 (d, Ar-CH=CHCOOEt), 127.5 (d, 2C, Ar-CH), 121.4 (d, Ar-CH), 121.3 (d, 
Ar-CH), 115.6 (d, Ar-CH), 70.3 (t, PhCH2O), 60.6 (t, OCH2CH3), 14.2 (q, OCH2CH3) ppm. HR-




: 333.1097; found: 333.1103. 
 
      
    
Ethyl (2E)-3-(2-formyl-4-methoxyphenyl)acrylate (10c): General procedure-1 was carried out 
with ortho-bromobenzaldehyde 9c (430 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 mmol), PPh3 
(52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate (0.65 
mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9c)=0.75, Rf(10c)=0.60 (petroleum ether/ethyl 
acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 90:10 to 80:20) gave title compound 10c (421 mg, 90%), as brown semi-solid. IR (MIR-
ATR, 4000–600 cm-1): max=2922, 2852, 1709, 1601, 1497, 1464, 1292, 1263, 1180, 1161, 1098, 




H NMR (CDCl3, 400 MHz): δ=10.33 (s, 1H, CHO), 8.42 (d, 1H, J=16.1 
Hz, ArCH=CHCOOEt), 7.59 (d, 1H, J=8.8 Hz, Ar-H), 7.36 (d, 1H, J=2.9 Hz, Ar-H), 7.13 (dd, 
1H, J=8.8 and 2.9 Hz, Ar-H), 6.30 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.26 (q, 2H, J=7.3 Hz, 
OCH2CH3), 3.88 (s, 3H, Ar-OCH3), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 
100 MHz): δ=190.9 (d, CH=O), 166.4 (s, EtOC=O), 160.9 (s, Ar-C), 139.6 (d, Ar-
CH=CHCOOEt), 135.0 (s, Ar-C), 129.4 (d, Ar-CH), 129.3 (s, Ar-C), 121.2 (d, Ar-
CH=CHCOOEt), 120.7 (d, Ar-CH), 114.4 (d, Ar-CH), 60.6 (t, OCH2CH3), 55.6 (q, OCH3), 14.2 





found: 257.0788.  
 
 
   
Ethyl (2E)-3-[4-(benzyloxy)-2-formyl-5-methoxyphenyl]acrylate (10d): General procedure-1 
was carried out with ortho-bromobenzaldehyde 9d (642 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 
0.10 mmol), PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and 
ethyl acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9d)=0.60, Rf(10d)=0.50 
(petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 90:10 to 80:20) gave title compound 10d (632 mg, 93%), pale 
yellow viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max=2923, 1710, 1683, 1590, 1513, 




H NMR (CDCl3, 400 MHz): δ=10.24 (s, 1H, 
CHO), 8.43 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.43 (d, 2H, J=7.8 Hz, Ar-H), 7.42 (s, 1H, 
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Ar-H), 7.36 (dd, 2H, J=7.8 and 7.3 Hz, Ar-H), 7.30 (t, 1H, J=7.3 Hz, Ar-H), 7.05 (s, 1H, Ar-H), 
6.33 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 5.19 (s, 2H, PhCH2O), 4.27 (q, 2H, J=7.3 Hz, 
OCH2CH3), 3.95 (s, 3H, Ar-OCH3), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 
100 MHz): δ=189.1 (d, CH=O), 166.2 (s, EtOC=O), 154.1 (s, Ar-C), 149.6 (s, Ar-C), 139.4 (d, 
Ar-CH=CHCOOEt), 135.8 (s, Ar-C), 131.7 (s, Ar-C), 128.6 (d, 2C, Ar-CH), 128.2 (d, Ar-CH), 
127.5 (s, Ar-C), 127.4 (d, 2C, Ar-CH), 121.8 (d, Ar-CH=CHCOOEt), 113.2 (d, Ar-CH), 109.3 
(d, Ar-CH), 70.9 (t, PhCH2O), 60.7 (t, OCH2CH3), 56.1 (t, Ar-OCH3) , 14.2 (q, OCH2CH3) ppm. 








Ethyl (2E)-3-[5-(benzyloxy)-2-formyl-4-methoxyphenyl]acrylate (10e): General procedure-1 
was carried out with ortho-bromobenzaldehyde 9e (642 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 
0.10 mmol), PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and 
ethyl acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9e)=0.60, Rf(10e)=0.50 
(petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 85:15 to 75:25) gave title compound 10e (639 mg, 94%), as orange 
solid (recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 124–126 C. IR 
(MIR-ATR, 4000–600 cm-1): max=2922, 2852, 1709, 1680, 1589, 1513, 1356, 1275, 1174, 1109, 




H NMR (CDCl3, 400 MHz): δ=10.29 (s, 1H, CHO), 8.40 (d, 1H, 
J=16.1 Hz, ArCH=CHCOOEt), 7.45–7.30 (m, 6H, Ar-H), 7.09 (s, 1H, Ar-H), 6.22 (d, 1H, 
J=16.1 Hz, ArCH=CHCOOEt), 5.22 (s, 2H, PhCH2O), 4.26 (q, 2H, J=7.3 Hz, OCH2CH3), 3.94 
(s, 3H, Ar-OCH3), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): 
δ=189.1 (d, CH=O), 166.2 (s, EtOC=O), 152.7 (s, Ar-C), 151.0 (s, Ar-C), 139.3 (d, Ar-CH=CH-
COOEt), 135.6 (s, Ar-C), 131.3 (s, Ar-C), 128.7 (d, 2C, Ar-CH), 128.3 (d, Ar-CH), 127.8 (s, Ar-
C), 127.3 (d, 2C, Ar-CH), 121.8 (d, Ar-CH=CHCOOEt), 111.4 (d, Ar-CH), 111.0 (d, Ar-CH), 
70.9 (t, PhCH2O), 60.7 (t, OCH2CH3), 56.1 (q, OCH3) , 14.2 (q, OCH2CH3) ppm. HR-MS (ESI+) 











Ethyl (2E)-3-(6-formyl-1,3-benzodioxol-5-yl)acrylate (10f): General procedure-1 was carried 
out with ortho-bromobenzaldehyde 9f (458 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 mmol), 
PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate 
(0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9f)=0.75, Rf(10f)=0.55 (petroleum 
ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 80:20) gave title compound 10f (461 mg, 93%), as yellow solid (recrystallized 
from a mixture of petroleum ether/dichloromethane). m.p.: 112–114 C. IR (MIR-ATR, 4000–
600 cm
-1





H NMR (CDCl3, 400 MHz): δ=10.23 (s, 1H, CHO), 8.39 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 7.31 (s, 1H, Ar-H), 7.03 (s, 1H, Ar-H), 6.28 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 6.08 (s, 2H, OCH2O), 4.26 (q, 2H, J=7.3 Hz, OCH2CH3), 1.32 (t, 3H, J=7.3 
Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=188.7 (d, CH=O), 166.2 (s, EtOC=O), 
152.5 (s, Ar-C), 149.5 (s, Ar-C), 139.3 (d, Ar-CH=CHCOOEt), 133.8 (s, Ar-C), 129.5 (s, Ar-C), 
122.3 (d, Ar-CH=CHCOOEt), 108.8 (d, Ar-CH), 106.7 (d, Ar-CH), 102.4 (t, OCH2O), 60.8 (t, 









Ethyl (2E)-3-(2-formyl-4,5-dimethoxyphenyl)acrylate (10g): General procedure-1 was carried 
out with ortho-bromobenzaldehyde 9g (490 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 mmol), 
PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate 
(0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9g)=0.50, Rf(10g)=0.40 (petroleum 
ether/ethyl acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 80:20 to 70:30) gave title compound 10g (483 mg, 93%), as orange solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 110–112 C. IR (MIR-





H NMR (CDCl3, 400 MHz): δ=10.27 (s, 1H, CHO), 8.40 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 7.34 (s, 1H, Ar-H), 7.01 (s, 1H, Ar-H), 6.31(d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 4.24 (q, 2H, J=7.3, OCH2CH3), 3.94 (s, 3H, Ar-OCH3), 3.92 (s, 3H, Ar-
OCH3), 1.30 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=189.0 (d, 
CH=O), 166.1 (s, EtOC=O), 153.5 (s, Ar-C), 150.5 (s, Ar-C), 139.2 (d, Ar-CH=CHCOOEt), 
131.5 (s, Ar-C), 127.6 (s, Ar-C), 121.8 (d, Ar-CH=CHCOOEt), 111.0 (d, Ar-CH), 108.9 (d, Ar-
CH), 60.7 (t, OCH2CH3), 56.1 (q, Ar-OCH3), 56.0 (q, Ar-OCH3), 14.2 (q, OCH2CH3) ppm. HR-









   
Ethyl (2E)-3-(6-formyl-2,3,4-trimethoxyphenyl)acrylate (10h): General procedure-1 was 
carried out with ortho-bromobenzaldehyde 9h (552 mg, 2.0 mmol), Pd(OAc)2 (22.5 mg, 0.10 
mmol), PPh3 (52.4 mg, 0.20 mmol), Et3N (607 mg, 6.00 mmol), dry toluene (2 mL) and ethyl 
acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(9h)=0.40, Rf(10h)=0.30 
(petroleum ether/ethyl acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 80:20 to 70:30) gave title compound 10h (548 mg, 93%), as pink 
solid (recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 72–74 C. IR 
(MIR-ATR, 4000–600 cm-1): max= 2923, 2852, 1714, 1687, 1583, 1488, 1461, 1330, 1301, 




H NMR (CDCl3, 400 MHz): δ=10.13 (s, 1H, CHO), 8.04 
(d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.26 (s, 1H, Ar-H), 6.21 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 4.25 (q, 2H, J=7.3 Hz, OCH2CH3), 3.93 (s, 3H, Ar-OCH3), 3.91(s, 3H, Ar-
OCH3), 3.85 (s, 3H, Ar-OCH3), 1.31 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 
MHz): δ=189.9 (d, CH=O), 166.1 (s, EtOC=O), 154.1 (s, Ar-C), 152.4 (s, Ar-C), 147.0 (s, Ar-C), 
135.6 (d, Ar-CH=CHCOOEt), 130.3 (s, Ar-C), 126.4 (d, Ar-CH=CHCOOEt), 126.2 (s, Ar-C), 
107.2 (d, Ar-CH), 61.1 (q, Ar-OCH3), 61.0 (q, Ar-OCH3), 60.7 (t, OCH2CH3), 56.1 (q, Ar-





317.0996; found: 317.1000.  
 
General Procedure-2 for Pd-mediated heck reaction ortho-bromoacetophenone (13a-13h): 
To a stirred solution of an oven dried Schlenk tube under nitrogen atmosphere, were added 
ortho-bromoacetophenone 13a-13h (2.0 mmol), Pd(OAc)2 (5 mol%), PPh3 (10 mol%) and 
DIPEA (6.0 mmol), dry toluene (5 mL) and followed by addition of ethyl acrylate (6.0 mmol). 
The resulted reaction mixture was stirred at 110 C for 24 h. The reaction mixture was quenched 
by addition of aqueous NH4Cl and the aqueous layer was extracted with ethyl acetate (3  20 
mL). The combined organic layers were dried (Na2SO4) and concentrated in vacuo. The crude 
product 14a-14h was purified by column chromatography on silica using petroleum ether/ethyl 






Ethyl (2E)-3-(2-acetylphenyl)acrylate (14a): General procedure-2 was carried out with ortho-
bromoacetophenone 13a (398 mg, 2.0 mmol), Pd(OAc)2 (22.4 mg, 0.10 mmol), PPh3 (52.4 mg, 
0.20 mmol), DIPEA (775.2 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate (0.65 mL, 6.0 
mmol) at 110 C for 24 h [TLC control Rf(13a)=0.50, Rf(13h)=0.35 (petroleum ether/ethyl 
acetate 90:10, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 95:5 to 90:10) gave title compound 13a (379 mg, 87%), as orange semi-solid. IR (MIR-
ATR, 4000–600 cm-1): max= 2923, 2852, 1711, 1682, 1634, 1364, 1315, 1278, 1251, 1178, 




H NMR (CDCl3, 400 MHz): δ= 8.12 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 7.72 (dd, 1H, J=7.3 and 1.5 Hz, Ar-H), 7.56 (dd, 1H, J=7.8 and 1.5 Hz, Ar-
H), 7.50 (ddd, 1H, J=7.8, 7.3 and 1.5 Hz, Ar-H), 7.43 (ddd, 1H, J=7.8, 7.3 and 1.5 Hz, Ar-H), 
6.26 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.24 (q, 2H, J=7.3 Hz, OCH2CH3), 2.59 (s, 3H, 
COCH3), 1.31 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ= 200.8 (s, 
C=O), 166.5 (s, O=COEt), 143.8 (d, Ar-CH=CHCOOEt), 138.2 (s, Ar-C), 134.8 (s, Ar-C), 131.9 
(d, Ar-CH), 129.3 (d, Ar-CH), 129.1(d, Ar-CH=CHCOOEt), 128.3 (d, Ar-CH), 120.9 (d, Ar-









Ethyl (2E)-3-(2-acetyl-4-methoxyphenyl)acrylate (14c): General procedure-2 was carried out 
with ortho-bromoacetophenone 13c (458 mg, 2.0 mmol), Pd(OAc)2 (22.4 mg, 0.10 mmol), PPh3 
(52.4 mg, 0.20 mmol), DIPEA (775.2 mg, 6.00 mmol), dry toluene (5 mL) and ethyl acrylate 
(0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(13c)=0.40, Rf(14c)=0.30 (petroleum 
ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 90:10 to 85:15) gave title compound 14c (472 mg, 95%), as yellow liquid. IR 
(MIR-ATR, 4000–600 cm-1): max= 2921, 2851, 1708, 1687, 1633, 1601, 1489, 1295, 1271, 




H NMR (CDCl3, 400 MHz): δ= 8.01 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 7.56 (d, 1H, J=8.8 Ar-H), 7.16 (d, IH, J=2.9, Ar-H), 7.02 (dd, 1H, J=8.8 and 
2.9, Ar-H), 6.22 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.24 (q, 2H, J=7.3 Hz, OCH2CH3), 3.86 





(CDCl3, 100 MHz): δ= 201.1 (s, C=O), 166.7 (s, O=COEt), 160.3 (s, Ar-C), 142.8 (d, Ar-
CH=CHCOOEt), 140.3 (s, Ar-C), 129.6 (d, Ar-CH), 126.5 (s, Ar-C), 119.1 (d, Ar-
CH=CHCOOEt), 116.8 (d, Ar-CH), 114.5 (d, Ar-CH), 60.4 (t, OCH2CH3), 55.6 (q, Ar-OCH3), 





: 287.0680; found: 287.0675.  
 
 
    
Ethyl (2E)-3-(6-acetyl-1,3-benzodioxol-5-yl)acrylate (14f): General procedure-2 was carried 
out with ortho-bromoacetophenone 13f (482 mg, 2.0 mmol), Pd(OAc)2 (22.4 mg, 0.10 mmol), 
PPh3 (52.4 mg, 0.20 mmol), DIPEA (775.2 mg, 6.00 mmol), dry toluene (5 mL) and ethyl 
acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(13f)=0.45, Rf(14f)=0.30 
(petroleum ether/ethyl acetate 90:10, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 90:10 to 85:15) gave title compound 14f (430 mg, 83%), as yellow 
viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max= 2921, 2852, 1708, 1680, 1632, 1508, 




H NMR (CDCl3, 400 MHz): δ= 8.07 
(d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.16 (s, IH, Ar-H), 7.00 (s, 1H, Ar-H), 6.16 (d, 1H, 
J=16.1 Hz, ArCH=CHCOOEt), 6.05 (s, 2H, OCH2O), 4.23 (q, 2H, J=7.3 Hz, OCH2CH3), 2.53 
(s, 3H, COCH3) 1.30 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ= 199.0 
(s, C=O), 166.6 (s, O=COEt), 150.5 (s, Ar-C), 148.5 (s, Ar-C), 143.6 (d, Ar-CH=CHCOOEt), 
133.1 (s, Ar-C), 130.9 (s, Ar-C), 119.8 (d, Ar-CH=CHCOOEt), 109.1 (d, Ar-CH), 107.7 (d, Ar-
CH), 102.3 (t, OCH2O), 60.5, (t, OCH2CH3), 29.2 (q, COCH3), 14.3 (q, OCH2CH3) ppm. HR-MS 




: 285.0733; found: 285.0738.  
 
  
Ethyl (2E)-3-(2-acetyl-4,5-dimethoxyphenyl)acrylate (14g): General procedure-2 was carried 
out with ortho-bromoacetophenone 13g (518 mg, 2.0 mmol), Pd(OAc)2 (22.4 mg, 0.10 mmol), 
PPh3 (52.4 mg, 0.20 mmol), DIPEA (775.2 mg, 6.00 mmol), dry toluene (5 mL) and ethyl 
acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(13g)=0.40, Rf(14g)=0.30 
(petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 90:10 to 80:20) gave title compound 14g (473 mg, 85%), as brown 
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viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max= 2924, 2852, 1705, 1674, 1631, 1596, 




H NMR (CDCl3, 400 MHz): δ= 8.18 (d, 
1H, J=16.1 Hz, ArCH=CHCOOEt), 7.22 (s, 1H, Ar-H), 7.04 (s, IH, Ar-H), 6.24 (d, 1H, J=16.1 
Hz, ArCH=CHCOOEt), 4.27 (q, 2H, J=7.3 Hz, OCH2CH3), 3.96 (s, 6H, Ar-OCH3), 2.60 (s, 3H, 
COCH3) 1.34 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ= 199.2 (s, 
C=O), 166.6 (s, O=COEt), 151.6 (s, Ar-C), 149.4 (s, Ar-C), 143.8 (d, Ar-CH=CHCOOEt), 131.3 
(s, Ar-C), 128.9 (s, Ar-C), 119.6 (d, Ar-CH=CHCOOEt), 111.9 (d, Ar-CH), 110.1 (d, Ar-CH), 
60.4 (t, OCH2CH3), 56.1 (q, Ar-OCH3), 56.0 (q, Ar-OCH3), 29.3 (q, COCH3), 14.2 (q, 









Ethyl (2E)-3-(6-acetyl-2,3,4-trimethoxyphenyl)acrylate (14h): General procedure-2 was 
carried out with ortho-bromoacetophenone 13h (576 mg, 2.0 mmol), Pd(OAc)2 (22.4 mg, 0.10 
mmol), PPh3 (52.4 mg, 0.20 mmol), DIPEA (775.2 mg, 6.00 mmol), dry toluene (5 mL) and 
ethyl acrylate (0.65 mL, 6.0 mmol) at 110 C for 24 h [TLC control Rf(13h)=0.40, Rf(14h)=0.25 
(petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 80:20 to 75:25) gave title compound 14h (517 mg, 84%), as yellow 
viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max= 2917, 2849, 1712, 1584, 1462, 1328, 1302, 




H NMR (CDCl3, 400 MHz): δ= 7.78 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 6.80 (s, 1H, Ar-H), 6.29 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.20 (q, 2H, 
J=7.3 Hz, OCH2CH3), 3.88 (s, 3H, Ar-OCH3), 3.86 (s, 3H, Ar-OCH3), 3.81 (s, 3H, Ar-OCH3), 
2.46 (s, 3H, COCH3), 1.28 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ= 
202.3 (s, C=O), 166.8 (s, O=COEt), 153.8 (s, Ar-C), 153.0 (s, Ar-C), 144.4 (s, Ar-C), 138.3 (d, 
Ar-CH=CHCOOEt), 136.9 (s, Ar-C), 123.2 (d, Ar-CH), 120.7 (d, Ar-CH), 107.2 (d, Ar-
CH=CHCOOEt), 60.9 (q, Ar-OCH3), 60.8 (q, Ar-OCH3), 60.4 (t, OCH2CH3), 56.1 (q, Ar-





: 331.1152; found: 331.1151.  
 
 
General Procedure-3 (For primary alcohols): To magnetically stirred solution of an aldehyde 
ester 10a-10h (0.50 mmol) in AcOH (2 mL), was added sodium borohydride (2.0 mmol). Then 
the reaction mixture was stirred at rt for 1.5 h. The reaction mixture was quenched by addition of 
aqueous NaHCO3 solution and extracted with ethyl acetate (3  15 mL). The organic layer was 
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washed with saturated NaCl solution, dried over Na2SO4. Evaporation of the organic layer under 
reduced pressure and purification of the crude material by silica gel column chromatography 




Ethyl (2E)-3-[2-(hydroxymethyl)phenyl)acrylate (15a): General procedure-3 was carried with 
an aldehyde ester 10a (102 mg, 0.50 mmol) and NaBH4 (74.6 mg, 2.0 mmol) in AcOH (2 mL) 
for 1.5 h at rt, [TLC control Rf(10a)=0.85, Rf(15a)=0.40 (petroleum ether/ethyl acetate 80:20, 
UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 85:15 to 
80:20) gave title compound 15a (92 mg, 89%), as brown viscous liquid. IR (MIR-ATR, 4000–
600 cm
-1





H NMR (CDCl3, 400 MHz): δ=8.02 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.58 (d, 1H, 
J=7.3, Ar-H), 7.43 (d, 1H, J=7.3, Ar-H), 7.37 (dd, 1H, J=7.3 and 7.3 Hz, Ar-H), 7.31 (dd, 1H, 
J=7.3 and 7.3 Hz, Ar-H), 6.38 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.80 (s, 2H, CH2OH), 4.25 
(q, 2H, J=7.3, OCH2CH3), 2.59 (br. s, 1H, OH), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C 
NMR (CDCl3, 100 MHz): δ=167.0 (s, O=COEt), 141.4 (d, Ar-CH=CHCOOEt), 139.6 (s, Ar-C), 
133.0 (s, Ar-C), 130.1 (d, Ar-CH), 128.7 (d, Ar-CH), 128.1 (d, Ar-CH), 126.7 (d, Ar-
CH=CHCOOEt), 120.1 (d, Ar-CH), 62.7 (t, CH2OH), 60.6 (t, OCH2CH3), 14.2 (q, OCH2CH3) 




: 229.0835; found: 229.0844.  
 
 
    
Ethyl (2E)-3-[4-(benzyloxy)-2-(hydroxymethyl)phenyl]acrylate (15b): General procedure-3 
was carried with an aldehyde ester 10b (155 mg, 0.50 mmol) and NaBH4 (74.6 mg, 2.0 mmol) in 
AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10b)=0.60, Rf(15b)=0.40 (petroleum ether/ethyl 
acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 85:15 to 80:20) gave title compound 15b (123 mg, 79%), as pale orange solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 94–96 C. IR (MIR-
ATR, 4000–600 cm-1): max= 3433, 2923, 2853, 1705, 1601, 1495, 1455, 1294, 1255, 1160, 




H NMR (CDCl3, 400 MHz): δ=7.91 (d, 1H, J=15.6 Hz, 
ArCH=CHCOOEt), 7.54 (d, 1H, J=8.8 Hz, Ar-H) , 7.45–7.30 (m, 5H, Ar-H), 7.08 (d, 1H, 
J=2.9), 6.89 (d, 1H, J=8.8 Hz, Ar-H), 6.27 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 5.07 (s, 2H, 
PhCH2O), 4.78 (s, 2H, CH2OH), 4.23 (q, 2H, J=7.3 Hz, OCH2CH3), 2.03 (br. s, 1H, CH2OH), 
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1.31 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=167.4 (s, EtOC=O), 
160.4 (s, Ar-C), 141.7 (s, Ar-C), 140.7 (d, Ar-CH=CHCOOEt), 136.4 (s, Ar-C), 128.6 (d, 2C, 
Ar-CH), 128.4 (d, Ar-CH), 128.1 (d, Ar-CH), 127.4 (d, 2C, Ar-CH), 125.3 (s, Ar-C), 117.6 (d, 
Ar-CH=CHCOOEt), 114.4 (d, Ar-CH), 114.3 (d, Ar-CH), 70.0 (t, PhCH2O), 62.6 (t, CH2OH), 





: 335.1254; found: 335.1257.  
 
  
Ethyl (2E)-3-[2-(hydroxymethyl)-4-methoxyphenyl]acrylate (15c): General procedure-3 was 
carried with an aldehyde ester 10c (117 mg, 0.50 mmol) and NaBH4 (74.6 mg, 2.0 mmol) in 
AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10c)=0.60, Rf(15c)=0.40 (petroleum ether/ethyl 
acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 85:15 to 80:20) gave title compound 15c (92 mg, 78%), as yellow viscous liquid. IR 
(MIR-ATR, 4000–600 cm-1): max=3433, 2924, 1704, 1630, 1601, 1496, 1464, 1296, 1256, 1179, 




H NMR (CDCl3, 400 MHz): δ=7.89 (d, 1H, J=15.6 Hz, 
ArCH=CHCOOEt), 7.53 (d, 1H, J=8.8 Hz, Ar-H), 6.99 (d, 1H, J=2.9 Hz, Ar-H), 7.81 (dd, 1H, 
J=8.8 and 2.9 Hz, Ar-H), 6.25 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 4.78 (s, 2H, CH2OH), 4.21 
(q, 2H, J=7.3 Hz, OCH2CH3), 3.80 (s, 3H, Ar-OCH3), 2.02 (br. s, 1H, CH2OH), 1.30 (t, 3H, 
J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=167.4 (s, EtOC=O), 161.2 (s, Ar-C), 
141.7 (s, Ar-C), 140.8 (d, Ar-CH=CHCOOEt), 128.3 (d, Ar-CH), 125.0 (s, Ar-C), 117.4 (d, Ar-
CH=CHCOOEt), 113.6 (d, Ar-CH), 113.4 (d, Ar-CH), 62.5 (t, CH2OH), 60.4 (t, OCH2CH3), 





: 259.0941; found: 259.0946.   
 
   
Ethyl (2E)-3-[4-(benzyloxy)-2-(hydroxymethyl)-5-methoxyphenyl]acrylate (15d): General 
procedure-3 was carried with an aldehyde ester 10d (170 mg, 0.50 mmol) and NaBH4 (74.6 mg, 
2.0 mmol) in AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10d)=0.50, Rf(15d)=0.40 (petroleum 
ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 85:15 to 80:20) gave title compound 15d (164 mg, 96%), as yellow solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 114–116 C. IR (MIR-





H NMR (CDCl3, 400 MHz): δ=7.93 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.42 
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(d, 2H, J=6.8 Hz, Ar-H), 7.36 (dd, 2H, J=7.3 and 6.8 Hz, Ar-H), 7.31 (t, 1H, J=7.3 Hz, Ar-H), 
7.09 (s, 1H, Ar-H), 6.98 (s, 1H, Ar-H) , 6.29 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 5.15 (s, 2H, 
PhCH2O), 4.70 (s, 2H, CH2OH), 4.24 (q, 2H, J=7.3 Hz, OCH2CH3), 3.88 (s, 3H, Ar-OCH3), 2.36 
(br. s, 1H, CH2OH), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3). 
13
C NMR (CDCl3, 100 MHz): δ=167.2 
(s, EtOC=O), 150.0 (s, Ar-C), 149.0 (s, Ar-C), 140.8 (d, Ar-CH=CH-COOEt), 136.4 (s, Ar-C), 
133.5 (s, Ar-C), 128.5 (d, 2C, Ar-CH), 128.0 (d, Ar-CH), 127.3 (d, 2C, Ar-CH), 125.4 (s, Ar-C), 
117.6 (d, Ar-CH=CHCOOEt), 113.7 (d, Ar-CH), 109.4 (d, Ar-CH), 70.7 (t, PhCH2O), 62.1 (t, 





: 365.1359; found: 365.1362.  
 
  
Ethyl (2E)-3-[5-(benzyloxy)-2-(hydroxymethyl)-4-methoxyphenyl]acrylate (15e): General 
procedure-3 was carried with an aldehyde ester 10e (170 mg, 0.50 mmol) and NaBH4 (74.6 mg, 
2.0 mmol) in AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10e)=0.50, Rf(15e)=0.40 (petroleum 
ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 85:15 to 80:20) gave title compound 15e (147 mg, 86%), as pale yellow solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 126–128 C. IR (MIR-





H NMR (CDCl3, 400 MHz): δ=7.90 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.43 (d, 
2H, J=7.3 Hz, Ar-H), 7.36 (dd, 2H, J=7.3 and 7.3 Hz, Ar-H), 7.30 (t, 1H, J=7.3 Hz, Ar-H), 7.11 
(s, 1H, Ar-H), 6.96 (s, 1H, Ar-H), 6.16 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 5.12 (s, 2H, 
PhCH2O), 4.74 (s, 2H, CH2OH), 4.22 (q, 2H, J=7.3 Hz, OCH2CH3), 3.88 (s, 3H, Ar-OCH3), 2.55 
(br. s, 1H, CH2OH), 1.31 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): 
δ=167.2 (s, EtOC=O), 151.5 (s, Ar-C), 147.6 (s, Ar-C), 140.7 (d, Ar-CH=CH-COOEt), 136.6 (s, 
Ar-C), 134.1 (s, Ar-C), 128.6 (d, 2C, Ar-CH), 128.0 (d, Ar-CH), 127.4 (d, 2C, Ar-CH), 125.0 (s, 
Ar-C), 117.5 (d, Ar-CH=CHCOOEt), 111.9 (d, Ar-CH), 111.8 (d, Ar-CH), 71.1 (t, PhCH2O), 
62.2 (t, CH2OH), 60.5 (t, OCH2CH3), 55.9 (q, Ar- OCH3) , 14.3 (q, OCH2CH3) ppm. HR-MS 




: 365.1359; found: 365.1359.  
 
   
Ethyl (2E)-3-[6-(hydroxymethyl)-1,3-benzodioxol-5-yl]acrylate (15f) : General procedure-3 
was carried with an aldehyde ester 10f (124 mg, 0.50 mmol) and NaBH4 (74.6 mg, 2.0 mmol) in 
AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10f)=0.75, Rf(15f)=0.40 (petroleum ether/ethyl 
acetate 70:30, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 80:20 to 70:30) gave title compound 15f (113 mg, 90%), as yellow solid (recrystallized 









H NMR (CDCl3, 400 MHz): δ=7.89 
(d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 7.03 (s, 1H, Ar-H), 6.89 (s, 1H, Ar-H), 6.16 (d, 1H, 
J=15.6 Hz, ArCH=CHCOOEt), 5.96 (s, 2H, OCH2O), 4.70 (s, 2H, CH2OH), 4.21 (q, 2H, J=7.3 
Hz, OCH2CH3), 2.59 (br. s, 1H, CH2OH), 1.30 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR 
(CDCl3, 100 MHz): δ=167.2 (s, EtOC=O), 149.4 (s, Ar-C), 147.6 (s, Ar-C), 140.6 (d, Ar-
CH=CHCOOEt), 135.3 (s, Ar-C), 126.6 (s, Ar-C), 117.8 (d, Ar-CH=CHCOOEt), 109.0 (d, Ar-
CH), 105.9 (d, Ar-CH), 101.5 (t, OCH2O), 62.3 (t, CH2OH), 60.5 (t, OCH2CH3), 14.2 (q, 




: 273.0733; found: 
273.0730. 
 
   
Ethyl (2E)-3-[2-(hydroxymethyl)-4,5-dimethoxyphenyl]acrylate (15g): General procedure-3 
was carried with an aldehyde ester 10g (132 mg, 0.50 mmol) and NaBH4 (74.6 mg, 2.0 mmol) in 
AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10g)=0.50, Rf(15g)=0.40 (petroleum ether/ethyl 
acetate 70:40, UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl 
acetate 70:30 to 60:40) gave title compound 15g (121 mg, 91%), as brown solid (recrystallized 
from a mixture of petroleum ether/dichloromethane). m.p.: 72–74 C. IR (MIR-ATR, 4000–600 
cm
-1





H NMR (CDCl3, 400 MHz): δ=7.93 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 7.05 (s, 1H, 
Ar-H), 6.93 (s, 1H, Ar-H), 6.26 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.76 (t, 2H, CH2OH), 
4.22 (q, 2H, J=7.3, OCH2CH3), 3.88 (s, 3H, Ar-OMe), 3.87 (s, 3H, Ar-OMe), 2.46 (br. s, 1H, 
CH2OH), 1.30 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=167.2 (s, 
EtOC=O), 150.7 (s, Ar-C), 148.5 (s, Ar-C), 140.8 (d, Ar-CH=CHCOOEt), 133.6 (s, Ar-C), 125.0 
(s, Ar-C), 117.5 (d, Ar-CH=CHCOOEt), 111.5 (d, Ar-CH), 108.8 (d, Ar-CH), 62.2 (t, CH2OH), 





: 289.1046; found: 289.1057.  
  
Ethyl (2E)-3-[6-(hydroxymethyl)-2, 3, 4-trimethoxyphenyl]acrylate (15h): General 
procedure-3 was carried with an aldehyde ester 10h (148 mg, 0.50 mmol) and NaBH4 (74.6 mg, 
2.0 mmol) in AcOH (2 mL) for 1.5 h at rt, [TLC control Rf(10h)=0.50, Rf(15h)=0.30 (petroleum 
ether/ethyl acetate 50:50, UV detection)]. Silica gel column chromatography (20 g, petroleum 
ether/ethyl acetate 60:40 to 50:50) gave title compound 15h (134 mg, 90%), as yellow solid 
(recrystallized from a mixture of petroleum ether/dichloromethane). m.p.: 78–80 C. IR (MIR-
ATR, 4000–600 cm-1): max=3482, 2922, 2852, 1710, 1627, 1590, 1489, 1462, 1406, 1329, 1301, 




H NMR (CDCl3, 400 MHz): δ=7.78 (d, 1H, J=16.1 Hz, 
ArCH=CHCOOEt), 6.84 (s, 1H, Ar-H), 6.55 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 4.72 (t, 2H, 
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CH2OH), 4.21 (q, 2H, J=7.3 Hz, OCH2CH3), 3.86 (s, 3H, Ar-OCH3), 3.83 (s, 6H, Ar-OCH3), 
2.69 (br. s, 1H, CH2OH), 1.30 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): 
δ=168.0 (s, EtOC=O), 154.3 (s, Ar-C), 153.7 (s, Ar-C), 141.6 (s, Ar-C), 137.5 (d, Ar-
CH=CHCOOEt), 136.5 (s, Ar-C), 121.3 (d, Ar-CH=CHCOOEt), 119.6 (s, Ar-C), 107.6 (d, Ar-
CH), 62.9 (t, OCH2CH3), 60.8 (q, Ar-OCH3), 60.6 (q, Ar-OCH3), 60.4 (t, CH2OH), 55.9 (t, Ar-





319.1152; found: 319.1153. 
 
 General Procedure-4 (For secondary alcohols): To a magnetically stirred solution of a 
acetophenone ester 14a-14h (0.5 mmol) in methanol (4 mL), was added CeCl3.7H2O (0.5 mmol) 
at 20 C followed by addition of sodium borohydride (1.0 mmol) after 10 mins at the same 
temperature. Then reaction mixture was stirred at rt for 12 h. Solvent was removed under 
reduced pressure, treated with aqueous 1 N HCl (10 mL) solution and extracted with DCM (3  
15 mL). The organic layer was washed with saturated NaCl solution, dried (Na2SO4), and 
filtered. Evaporation of the filtrate under reduced pressure and purification of the crude material 
by silica gel column chromatography (petroleum ether/ethyl acetate) furnished secondary alcohol 
ester 18a-18h (65–89%). 
 
 
   
Ethyl (2E)-3-[2-(1-hydroxyethyl)phenyl]acrylate (18a): General procedure-4 was carried out 
with acetophenone ester 14a (109 mg, 0.50 mmol) in methanol (4 mL), CeCl3.7H2O (186 mg, 
0.50 mmol), NaBH4 (37.3 mg, 1.0 mmol) at 20 C, [TLC control Rf(14a)=0.55, Rf(18a)=0.50 
(petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel column chromatography (20 g, 
petroleum ether/ethyl acetate 90:10 to 80:20) gave title compound 18a (86 mg, 78%), as yellow 
viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max=2919, 2850, 1713, 1632, 1462, 1368, 1315, 




H NMR (CDCl3, 400 MHz): δ= 8.06 (d, 1H, J=15.6 Hz, 
ArCH=CHCOOEt), 7.59 (d, 1H, J=7.8 Hz, Ar-H), 7.51 (d, 1H, J=7.8, Ar-H), 7.39 (dd, 1H, J=7.8 
and 7.3 Hz, Ar-H), 7.26 (dd, 1H, J=7.8 and 7.3 Hz, Ar-H), 6.32 (d, 1H, J=15.6 Hz, 
ArCH=CHCOOEt), 5.27 (q, 1H, J=6.4 Hz, CHCH3 ), 4.24 (q, 2H, J=7.3 Hz, OCH2CH3), 2.62 
(br. s, 1H, OH), 1.46 (d, 3H, J=6.4 Hz , CHCH3), 1.33 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C 
NMR (CDCl3, 100 MHz): δ=166.9 (s, O=COEt), 144.7 (s, Ar-C), 141.5 (d, Ar-CH=CHCOOEt), 
131.7 (s, Ar-C), 130.2 (d, Ar-CH), 127.5 (d, Ar-CH), 126.7 (d, Ar-CH=CHCOOEt), 125.4 (d, 
Ar-CH), 120.3 (d, Ar-CH), 66.5 (d, CHCH3), 60.6 (t, OCH2CH3), 24.9 (q, CHCH3), 14.2 (q, 











   
Ethyl (2E)-3-[2-(1-hydroxyethyl)-4-methoxyphenyl]acrylate (18c): General procedure-4 was 
carried out with acetophenone ester 14c (124 mg, 0.50 mmol) in methanol (4 mL), CeCl3.7H2O 
(186 mg, 0.50 mmol), NaBH4 (37.3 mg, 1.0 mmol) at 20 C, [TLC control Rf(14c)=0.60, 
Rf(18c)=0.50 (petroleum ether/ethyl acetate 70:30, UV detection)]. Silica gel column 
chromatography (20 g, petroleum ether/ethyl acetate 85:15 to 80:20) gave title compound 18c 
(111 mg, 89%), as yellow viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max=3417, 2922, 




H NMR (CDCl3, 400 MHz): δ= 
7.96 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 7.51 (d, 1H, J=8.8 Ar-H), 7.15 (d, IH, J=2.9, Ar-H), 
6.81 (dd, 1H, J=8.8 and 2.9, Ar-H), 6.25 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 5.31 (q, 1H, 
J=6.4 Hz, CHCH3), 4.25 (q, 2H, J=7.3 Hz, OCH2CH3), 3.84 (s, 3H, Ar-OCH3), 1.88 (br. s, 1H, 
OH), 1.46 (d, 3H, J=6.4, CHCH3), 1.32 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 
100 MHz): δ=167.3 (s, O=COEt), 161.4 (s, Ar-C), 147.1 (s, Ar-C), 140.7 (d, Ar-
CH=CHCOOEt), 128.2 (d, Ar-CH), 123.9 (s, Ar-C), 117.6 (d, Ar-CH=CHCOOEt), 113.3 (d, Ar-
CH), 110.2 (d, Ar-CH), 66.2 (d, CHCH3), 60.4 (t, OCH2CH3), 55.2 (q, Ar-OCH3), 25.1 (q, 





273.1097; found: 273.1095.  
 
   
Ethyl (2E)-3-[6-(1-hydroxyethyl)-1, 3-benzodioxol-5-yl]acrylate (18f): General procedure-4 
was carried out with acetophenone ester 14f (131 mg, 0.50 mmol) in methanol (4 mL), 
CeCl3.7H2O (186 mg, 0.50 mmol), NaBH4 (37.3 mg, 1.0 mmol) at 20 C, [TLC control 
Rf(14f)=0.55, Rf(18f)=0.45 (petroleum ether/ethyl acetate 80:20, UV detection)]. Silica gel 
column chromatography (20 g, petroleum ether/ethyl acetate 85:15 to 80:20) gave title 
compound 18f (86 mg, 65%), as brown viscous liquid. IR (MIR-ATR, 4000–600 cm-1): max= 





NMR (CDCl3, 400 MHz): δ= 7.93 (d, 1H, J=15.6, Hz, ArCH=CHCOOEt), 7.09 (s, IH, Ar-H), 
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6.97 (s, 1H, Ar-H), 6.19 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 5.97 (d, 1H, J=12.2 Hz, 
OCHaHbO), 5.96 (d, 1H, J=12.2 Hz, OCHaHbO), 5.27 (q, 1H, J=6.4 Hz, CHCH3), 4.23 (q, 2H, 
J=7.3 Hz, OCH2CH3), 2.11 (br. s, 1H, CHOH), 1.42 (d, 3H, J=6.4, CHCH3), 1.31 (t, 3H, J=7.3 
Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 MHz): δ=167.1 (s, O=COEt), 149.7 (s, Ar-C), 147.1 
(s, Ar-C), 140.6 (s, Ar-C), 140.5 (d, Ar-CH=CHCOOEt), 125.1 (s, Ar-C), 118.2 (d, Ar-
CH=CHCOOEt), 105.7 (d, Ar-CH), 105.6 (d, Ar-CH), 101.5 (t, OCH2O), 66.0 (d, CHCH3), 60.5, 





: 287.0890; found: 287.0888.  
 
 
   
Ethyl (2E)-3-[2-(1-hydroxyethyl)-4, 5-dimethoxyphenyl]acrylate (18g): General procedure-4 
was carried out with acetophenone ester 14g (139 mg, 0.50 mmol) in methanol (4 mL), 
CeCl3.7H2O (186 mg, 0.50 mmol), NaBH4 (37.3 mg, 1.0 mmol) at 20 C, [TLC control 
Rf(14g)=0.50, Rf(18g)=0.40 (petroleum ether/ethyl acetate 70:30, UV detection)]. Silica gel 
column chromatography (20 g, petroleum ether/ethyl acetate 75:25 to 65:35) gave title 
compound 18g (108 mg, 77%), as pale yellow viscous liquid. IR (MIR-ATR, 4000–600 cm-1): 





H NMR (CDCl3, 400 MHz): δ= 7.93 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 7.09 (s, 1H, Ar-H), 
6.96 (s, 1H, Ar-H), 6.21 (d, 1H, J=15.6 Hz, ArCH=CHCOOEt), 5.27 (q, 1H, J=6.4 Hz, CHCH3), 
4.21 (q, 2H, J=7.3 Hz, OCH2CH3), 3.88 (s, 3H, Ar-OCH3), 3.84 (s, 3H, Ar-OCH3), 2.49 (br. s, 
1H, CHOH), 1.41 (d, 3H, J=6.4 Hz, CHCH3), 1.29 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR 
(CDCl3, 100 MHz): δ= 167.1 (s, O=COEt), 151.1 (s, Ar-C), 148.0 (s, Ar-C), 140.6 (d, Ar-
CH=CHCOOEt), 139.1 (s, Ar-C), 123.4 (s, Ar-C), 117.6 (d, Ar-CH=CHCOOEt), 108.5 (d, Ar-
CH), 108.0 (d, Ar-CH), 65.8 (d, CHCH3), 60.4 (t, OCH2CH3), 55.8 (q, 2C, Ar-OCH3), 25.4 (q, 





303.1203; found: 303.1201.  
 
   
Ethyl (2E)-3-[6-(1-hydroxyethyl)-2,3,4-trimethoxyphenyl]acrylate (18h): General procedure-
4 was carried out with acetophenone ester 14h (154 mg, 0.50 mmol) in methanol (4 mL), 
CeCl3.7H2O (186 mg, 0.50 mmol), NaBH4 (37.3 mg, 1.0 mmol) at 20 C, [TLC control 
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Rf(14h)=0.55, Rf(18h)=0.45 (petroleum ether/ethyl acetate 60:40, UV detection)]. Silica gel 
column chromatography (20 g, petroleum ether/ethyl acetate 70:30 to 60:40) gave title 
compound 18h (126 mg, 81%), as pale yellow viscous liquid. IR (MIR-ATR, 4000–600 cm-1): 





H NMR (CDCl3, 400 MHz): δ= 7.75 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 6.99 (s, 1H, Ar-H), 
6.50 (d, 1H, J=16.1 Hz, ArCH=CHCOOEt), 5.24 (m, 1H, CHCH3), 4.22 (m, 2H, OCH2CH3), 
3.88 (s, 3H, Ar-OCH3), 3.84 (s, 3H, Ar-OCH3), 3.81 (s, 3H, Ar-OCH3), 2.37 (br. s, 1H, CHOH), 
1.43 (d, 3H, J=5.8 Hz, CHCH3), 1.31 (t, 3H, J=7.3 Hz, OCH2CH3) ppm. 
13
C NMR (CDCl3, 100 
MHz): δ=167.8 (s, O=COEt), 154.5 (s, Ar-C), 153.0 (s, Ar-C), 141.9 (d, Ar-CH=CHCOOEt), 
137.1 (s, Ar-C), 121.7 (s, Ar-C), 118.5 (d, Ar-CH=CHCOOEt), 104.3 (d, Ar-CH), 104.1 (d, Ar-
CH), 66.2 (d, CHCH3), 60.8 (q, Ar-OCH3), 60.5 (q, Ar-OCH3), 60.4 (t, OCH2CH3), 55.9 (q, Ar-





: 333.1309; found: 333.1315.  
 
General Procedure-5 (For intramolecular cyclization): 
 
In an oven dried Schlenk tube, were added alcohol ester 15a-15h and 18a-18h (0.40 mmol), and 
Cs2CO3 (1.2 mmol) followed by the addition of DMF (4 mL) at rt under nitrogen atmosphere. 
The resulted reaction mixture was stirred at 120 C in an oil bath for 4h. The reaction was 
quenched by the addition of aqueous NH4Cl and extracted with ethylacetate (3 × 10 mL). The 
organic layer was washed with saturated NaCl solution, dried over Na2SO4, and filtered. 
Evaporation of the solvent under reduced pressure and purification of the crude material by silica 
gel column chromatography (petroleum ether/ethyl acetate) furnished lactenones 19a-19h (60–




2-Benzoxepin-3(1H)-one (19a): General procedure-5 was carried with an alcohol ester 15a 
(82.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 120 C [TLC control 
Rf(15a)=0.20, Rf(19a)=0.30 (petroleum ether/ethyl acetate 90:10, UV detection)]. Silica gel 
column chromatography (20 g, petroleum ether/ethyl acetate 95:5 to 90:10) gave title compound 





8-(Benzyloxy)-2-benzoxepin-3(1H)-one (19b): General procedure-5 was carried with an alcohol 
ester 15b (125.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 120 C 
[TLC control Rf(15b)=0.30, Rf(19b)=0.40 (petroleum ether/ethyl acetate 80:20, UV detection)]. 
Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 90:10 to 85:15) gave title 
compound 19b (86.0 mg, 81%). 
 
 
8-Methoxy-2-benzoxepin-3(1H)-one (19c): General procedure-5 was carried with an alcohol 
ester 15c (94.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 120 C 
[TLC control Rf(15c)=0.40, Rf(19c)=0.45 (petroleum ether/ethyl acetate 80:20, UV detection)]. 
Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 90:10 to 80:20) gave title 
compound 19c (46.0 mg, 60%). 
 
 
8-(Benzyloxy)-7-methoxy-2-benzoxepin-3(1H)-one (19d): General procedure-5 was carried 
with an alcohol ester 15d (137.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 
mL) at 120 C [TLC control Rf(15d)=0.40, Rf(19d)=0.45 (petroleum ether/ethyl acetate 80:20, 
UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 85:15 to 
75:25) gave title compound 19d (93.0 mg, 78%). 
  
 
7-(Benzyloxy)-8-methoxy-2-benzoxepin-3(1H)-one (19e): General procedure-5 was carried 
with an alcohol ester 15e (137.0mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 
mL) at 120 C [TLC control Rf(15e)=0.40, Rf(19e)=0.45 (petroleum ether/ethyl acetate 80:20, 
UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 80:20 to 





[1,3]Dioxolo[4,5-h][2]benzoxepin-7(5H)-one (19f): General procedure-5 was carried with an 
alcohol ester 15f (100.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 120 
C [TLC control Rf(15f)=0.30, Rf(19f)=0.40 (petroleum ether/ethyl acetate 70:30, UV 
detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 80:20 to 




7,8-Dimethoxy-2-benzoxepin-3(1H)-one (19g): General procedure-5 was carried with an 
alcohol ester 15g (106.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 
120 C [TLC control Rf(15g)=0.20, Rf(19g)=0.30 (petroleum ether/ethyl acetate 80:20, UV 
detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 75:25 to 
70:30) gave title compound 19g (84.0 mg, 95%). 
 
 
6,7,8-Trimethoxy-2-benzoxepin-3(1H)-one (19h): General procedure-5 was carried with an 
alcohol ester 15h (119.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 
120 C [TLC control Rf(15h)=0.30, Rf(19h)=0.40 (petroleum ether/ethyl acetate 80:20, UV 
detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 75:25 to 
70:30) gave title compound 19h (80 mg, 80%). 
 
  
1-Methyl-2-benzoxepin-3(1H)-one (20a): General procedure-5 was carried with an alcohol 
ester 18a (88.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 120 C 
[TLC control Rf(18a)=0.30, Rf(20a)=0.35 (petroleum ether/ethyl acetate 90:10, UV detection)]. 
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Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 90:10 to 85:15) gave title 
compound 20a (47.0 mg, 67%).  
 
 
8-Methoxy-1-methyl-2-benzoxepin-3(1H)-one (20c): General procedure-5 was carried with an 
alcohol ester 18c (100.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 mL) at 
120 C [TLC control Rf(18c)=0.35, Rf(20c)=0.40 (petroleum ether/ethyl acetate 80:20, UV 
detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 85:15 to 
80:20) gave title compound 20c (53.0 mg, 65%).  
 
 
7,8-Dimethoxy-1-methyl-2-benzoxepin-3(1H)-one (20g): General procedure-5 was carried 
with an alcohol ester 18g (112.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 
mL) at 120 C [TLC control Rf(18g)=0.40, Rf(20g)=0.45 (petroleum ether/ethyl acetate 60:30, 
UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 75:25 to 
65:35) gave title compound 20g (67.0 mg, 71%).  
 
 
    
6,7,8-Trimethoxy-1-methyl-2-benzoxepin-3(1H)-one (20h): General procedure-5 was carried 
with an alcohol ester 18h (124.0 mg, 0.40 mmol) and Cs2CO3 (391.0 mg1.2 mmol) in DMF (4 
mL) at 120 C [TLC control Rf(18h)=0.25, Rf(20h)=0.30 (petroleum ether/ethyl acetate 80:20, 
UV detection)]. Silica gel column chromatography (20 g, petroleum ether/ethyl acetate 75:25 to 
65:35) gave title compound 20h (86 mg, 80%), as yellow viscous liquid. IR (MIR-ATR, 4000–
600 cm
-1





NMR (CDCl3, 400 MHz): δ= 7.45 (d, 1H, J=12.2 Hz, ArCH=CHCOOEt), 6.77 (s, 1H, Ar-H), 
6.26 (d, 1H, J=12.2 Hz, ArCH=CHCOOEt), 5.18 (q, 1H, J=6.4 Hz, CHCH3), 3.93 (s, 3H, Ar-




C NMR (CDCl3, 100 MHz): δ=167.9 (s, O=COEt), 155.0 (s, Ar-C), 152.1 (s, Ar-C), 142.2 (s, 
Ar-C), 135.1 (d, Ar-CH=CHCOOEt), 135.0 (s, Ar-C), 122.5 (s, Ar-C), 120.8 (d, Ar-
CH=CHCOOEt), 104.0 (d, Ar-CH), 77.2 (d, CHCH3), 61.7 (q, Ar-OCH3), 61.0 (q, Ar-OCH3), 











C NMR Spectra for all compounds 








































































H NMR (400 MHz) spectrum of 10a in CDCl3 
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C NMR (100 MHz) spectrum of 10a in CDCl3     
 
 
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm






























































































































































C NMR (100 MHz) spectrum of 10b in CDCl3   
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C NMR (100 MHz) spectrum of 10c in CDCl3   
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C NMR (100 MHz) spectrum of 10d in CDCl3   
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C NMR (100 MHz) spectrum of 10e in CDCl3     


































































































































C NMR (100 MHz) spectrum of 10f in CDCl3 
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H NMR (400 MHz) spectrum of 10g in CDCl3 














































































C NMR (100 MHz) spectrum of 10g in CDCl3   
 

























































H NMR (400 MHz) spectrum of 10h in CDCl3  


















































































C NMR (100 MHz) spectrum of 10h in CDCl3     













































































H NMR (400 MHz) spectrum of 14a in CDCl3   
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C NMR (100 MHz) spectrum of 14a in CDCl3           
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H NMR (400 MHz) spectrum of 14c in CDCl3 














































































C NMR (100 MHz) spectrum of 14c in CDCl3        
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H NMR (400 MHz) spectrum of 14f in CDCl3 
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C NMR (100 MHz) spectrum of 14f in CDCl3        
 

















































H NMR (400 MHz) spectrum of 14g in CDCl3    
 













































































C NMR (100 MHz) spectrum of 14g in CDCl3  
 
















































































H NMR (400 MHz) spectrum of 14h in CDCl3     
 


















































































C NMR (100 MHz) spectrum of 14h in CDCl3   
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C NMR (100 MHz) spectrum of 15b in CDCl3   
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm



















































































































































C NMR (100 MHz) spectrum of 15c in CDCl3   
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C NMR (100 MHz) spectrum of 15d in CDCl3   
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C NMR (100 MHz) spectrum of 15e in CDCl3   
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C NMR (100 MHz) spectrum of 15f in CDCl3   






































































































































C NMR (100 MHz) spectrum of 15g in CDCl3   
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C NMR (100 MHz) spectrum of 15h in CDCl3  
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C NMR (100 MHz) spectrum of 18a in CDCl3   
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H NMR (400 MHz) spectrum of 18c in CDCl3 
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C NMR (100 MHz) spectrum of 18c in CDCl3   
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C NMR (100 MHz) spectrum of 18f in CDCl3   
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C NMR (100 MHz) spectrum of 18g in CDCl3     
































































































































































C NMR (100 MHz) spectrum of 18h in CDCl3     



































H NMR (400 MHz) spectrum of 19a in CDCl3   
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C NMR (100 MHz) spectrum of 19a in CDCl3      















































H NMR (400 MHz) spectrum of 19b in CDCl3  
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C NMR (100 MHz) spectrum of 19b in CDCl3      



















































































































C NMR (100 MHz) spectrum of 19c in CDCl3      











































































































































 13C NMR (100 MHz) spectrum of 19d in CDCl3     
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C NMR (100 MHz) spectrum of 19e in CDCl3      






































































































C NMR (100 MHz) spectrum of 19f in CDCl3       






































































































C NMR (100 MHz) spectrum of 19g in CDCl3        

































H NMR (400 MHz) spectrum of 19h in CDCl3   
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C NMR (100 MHz) spectrum of 19h in CDCl3      
































































































































C NMR (100 MHz) spectrum of 20a in CDCl3      



























































H NMR (400 MHz) spectrum of 20c in CDCl3 
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C NMR (100 MHz) spectrum of 20c in CDCl3      
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H NMR (400 MHz) spectrum of 20g in CDCl3    
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C NMR (100 MHz) spectrum of 20g in CDCl3       
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